PuraPharm Corporation Statistics
Total Valuation
HKG:1498 has a market cap or net worth of HKD 189.63 million. The enterprise value is 516.49 million.
Market Cap | 189.63M |
Enterprise Value | 516.49M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:1498 has 395.05 million shares outstanding.
Current Share Class | 395.05M |
Shares Outstanding | 395.05M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 33.47% |
Owned by Institutions (%) | n/a |
Float | 262.81M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.50 |
PB Ratio | 1.71 |
P/TBV Ratio | 3.07 |
P/FCF Ratio | 2.13 |
P/OCF Ratio | 1.82 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.50, with an EV/FCF ratio of 5.79.
EV / Earnings | -14.57 |
EV / Sales | 1.35 |
EV / EBITDA | 15.50 |
EV / EBIT | n/a |
EV / FCF | 5.79 |
Financial Position
The company has a current ratio of 0.55, with a Debt / Equity ratio of 3.27.
Current Ratio | 0.55 |
Quick Ratio | 0.20 |
Debt / Equity | 3.27 |
Debt / EBITDA | 10.82 |
Debt / FCF | 4.08 |
Interest Coverage | -0.80 |
Financial Efficiency
Return on equity (ROE) is -26.80% and return on invested capital (ROIC) is -2.24%.
Return on Equity (ROE) | -26.80% |
Return on Assets (ROA) | -1.51% |
Return on Invested Capital (ROIC) | -2.24% |
Return on Capital Employed (ROCE) | -8.40% |
Revenue Per Employee | 797,683 |
Profits Per Employee | -73,985 |
Employee Count | 479 |
Asset Turnover | 0.49 |
Inventory Turnover | 1.18 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -37.66% in the last 52 weeks. The beta is -0.02, so HKG:1498's price volatility has been lower than the market average.
Beta (5Y) | -0.02 |
52-Week Price Change | -37.66% |
50-Day Moving Average | 0.52 |
200-Day Moving Average | 0.61 |
Relative Strength Index (RSI) | 42.80 |
Average Volume (20 Days) | 99,438 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1498 had revenue of HKD 382.09 million and -35.44 million in losses. Loss per share was -0.09.
Revenue | 382.09M |
Gross Profit | 205.14M |
Operating Income | -18.86M |
Pretax Income | -29.14M |
Net Income | -35.44M |
EBITDA | 14.63M |
EBIT | -18.86M |
Loss Per Share | -0.09 |
Balance Sheet
The company has 36.90 million in cash and 363.76 million in debt, giving a net cash position of -326.86 million or -0.83 per share.
Cash & Cash Equivalents | 36.90M |
Total Debt | 363.76M |
Net Cash | -326.86M |
Net Cash Per Share | -0.83 |
Equity (Book Value) | 111.20M |
Book Value Per Share | 0.28 |
Working Capital | -222.63M |
Cash Flow
In the last 12 months, operating cash flow was 103.99 million and capital expenditures -14.81 million, giving a free cash flow of 89.18 million.
Operating Cash Flow | 103.99M |
Capital Expenditures | -14.81M |
Free Cash Flow | 89.18M |
FCF Per Share | 0.23 |
Margins
Gross margin is 53.69%, with operating and profit margins of -4.94% and -9.28%.
Gross Margin | 53.69% |
Operating Margin | -4.94% |
Pretax Margin | -7.63% |
Profit Margin | -9.28% |
EBITDA Margin | 3.83% |
EBIT Margin | -4.94% |
FCF Margin | 23.34% |
Dividends & Yields
HKG:1498 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -18.69% |
FCF Yield | 47.03% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:1498 has an Altman Z-Score of -0.41. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.41 |
Piotroski F-Score | n/a |